Financings Of The Fortnight: How To Read Conflicting Reports On VC Life-Sciences Activity
This article was originally published in The Pink Sheet Daily
Plus news on recent financings by Cleave Biosciences, Anacor Pharmaceuticals, Chimerix and Auris Medical.
You may also be interested in...
The newly formed Inception 3 will work to bring small molecule candidates for hearing loss, based on technology licensed from Stanford University, to IND-filing stage, at which point Roche will have the option to buy out the program.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Marinus Pharmaceuticals has transformed its finances and the prospects for its R&D pipeline over the past 12 months, and has just reported positive top-line results from the Phase III MARIGOLD study of its lead compound, ganaxolone.